Connection

Chong Yu to Incidence

Back to Details
This is a "connection" page, showing publications Chong Yu has written about Incidence.
Chong Yu
Connection Strength
0.107
Incidence
  1. Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non-small-cell lung cancer patients. Eur J Cancer. 2019 08; 117:107-115.
    View in: PubMed
    Score: 0.041
  2. Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality. PLoS One. 2017; 12(4):e0175794.
    View in: PubMed
    Score: 0.035
  3. Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003. Front Immunol. 2021; 12:626609.
    View in: PubMed
    Score: 0.012
  4. Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018; 13:867-874.
    View in: PubMed
    Score: 0.009
  5. High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan. Int J Antimicrob Agents. 2017 Sep; 50(3):491-495.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.